During shortages of FDA-approved products containing semaglutide, such as Ozempic, compounded semaglutide has been available as an alternative option
When activated, it stimulates insulin secretion in a glucose-dependent manner, meaning it helps the pancreas release more insulin only when blood sugar levels are high
This means that semaglutide tablets could technically be prescribed as a weight management treatment, but this will only be done at the discretion of a qualified and responsible prescriber
Semaglutide has also been associated with a very rare eye condition called non-arteritic anterior ischaemic optic neuropathy, or NAION
Tools such as the HAS-BLED score can help quantify bleeding risk in patients requiring anticoagulation
Patients should always consult their pharmacist or GP before starting any over-the-counter remedies to ensure compatibility with their diabetes treatment regimen